A new vitamin for Multiple Sclerosis

A new study looking at progressive Multiple Sclerosis is suggesting that a high dose vitamin may be of benefit.

High dose biotin 300mg was tried in 154 patients aged 18 to 75 years (average about 51 years) with primary or secondary progressive MS and an EDSS (disability shoe) score of 4.5 to 7 with person in the previous two years. 

The study was looking to see how many patients showed improvement in either the disability scale or a timed walking test at nine months and ongoing at one year.

Improvement occurred in 12% of those who were in the drug group, compared to zero in the placebo group.

A promising and hopeful result for progressive MS, which otherwise had no specific effective therapy.

American Academy of Neurology (AAN) 67th Annual Meeting. Clinical Trials Plenary Session. Presented April 24, 2015.

Leave a Reply